Endosc Int Open 2016; 04(05): E564-E571
DOI: 10.1055/s-0042-103238
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Clinical analysis of moderate-to-deep-sedation by nonmedical sedation practitioners in 597 patients undergoing gastrointestinal endoscopy: a retrospective study

Hermanus Vaessen
Department of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Centre Utrecht, the Netherlands
,
Elisabeth Bruens
Department of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Centre Utrecht, the Netherlands
,
Johannes Knape
Department of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Centre Utrecht, the Netherlands
› Author Affiliations
Further Information

Publication History

submitted: 02 November 2015

accepted after revision: 08 February 2016

Publication Date:
08 April 2016 (online)

Background and study aim: The purpose of this study was to evaluate whether moderate-to-deep sedation with propofol and alfentanil can be administered safely by nonmedical sedation practitioners, and the outcomes of this practice in the Netherlands. We retrospectively analyzed the occurrence of sedation-related complications in patients undergoing gastrointestinal endoscopic procedures.

Patients and methods: In this study, 597 adult patients consecutively underwent upper gastrointestinal endoscopic procedures. The health status of the patients was screened according to a standardized protocol, and the patients were sedated by trained nonmedical sedation practitioners. Their vital signs were continuously monitored and recorded. All patients received oxygen, and the depth of sedation was continuously assessed and recorded. Mild and severe complications were recorded and analyzed.

Results: All patients recovered uneventfully, and no mortality occurred. Overall, of the 597 sedated patients, 85 had mild and 4 had severe complications. Hypoxemia and upper airway obstruction, which were easily managed by trained nonmedical sedation practitioners, were the most common events. Hypotension was rare. No signs or symptoms suggestive of aspiration were reported.

Conclusion: Moderate-to-deep sedation has been and continues to be a risky medical procedure. Serious complications of propofol/opioid-based sedation, especially respiratory and cardiovascular adverse events, may occur. These complications need to be recognized rapidly and appropriately managed. Our study shows that well-trained nonmedical sedation practitioners can be entrusted to take responsibility for the safe administration of moderate-to-deep sedation.

 
  • References

  • 1 Hazeldine S, Fritschi L, Forbes G. Predicting patient tolerance of endoscopy with conscious sedation. Scand J Gastroenterol 2010; 45: 1248-1254
  • 2 Zakko SF, Seifert HA, Gross JB. A comparison of midazolam and diazepam for conscious sedation during colonoscopy in a prospective double-blind study. Gastrointest Endosc 1999; 49: 684-689
  • 3 Qadeer MA, Lopez AR, Dumot JA et al. Hypoxemia during moderate sedation for gastrointestinal endoscopy: causes and associations. Digestion 2011; 84: 37-45
  • 4 Girdler NM, Fairbrother KJ, Lyne JP et al. A randomised crossover trial of post-operative cognitive and psychomotor recovery from benzodiazepine sedation: effects of reversal with flumazenil over a prolonged recovery period. Br Dent J 2002; 192: 335-339
  • 5 Stanley TH. The history and development of the fentanyl series. J Pain Symptom Manage 1992; 7 Suppl 3: 3-S7
  • 6 Patel S, Vargo J, Khandwala F et al. Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam. Am J Gastroenterol 2005; 100: 2689-2695
  • 7 Heuss LT, Sughandaa SP, Degen LP. Endoscopy teams’ judgment of discomfort among patients undergoing colonoscopy – how bad was it really?. Swiss Med Wkly 2012; 142: w13726
  • 8 Cohen LB, Wecsler JS, Gaetano JN et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 2006; 101: 967-974
  • 9 Jung M, Hofmann C, Kiesslich R et al. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam. Endoscopy 2000; 32: 233-238
  • 10 Knape JTA, van Everdingen JJE. Consensus sedatie en analgesie door artsen-niet-anesthesiologen. Ned Tijdschr Geneeskde 1999; 143: 1098-1102
  • 11 Mak PH, Campbell RC, Irwin MG. American Society of Anesthesiologists. The ASA Physical Status Classification: inter-observer consistency. American Society of Anesthesiologists. Anaesth Intensive Care 2002; 30: 633-640
  • 12 Mallampati SR. Clinical sign to predict difficult tracheal intubation (hypothesis). Can Anaesth Soc J 1983; 30: 316-317
  • 13 Mallampati SR, Gatt SP, Gugino LD et al. A clinical sign to predict difficult tracheal intubation: a prospective study. Can Anaesth Soc J 1985; 32: 429-434
  • 14 Dripps RD. New classification of physical status. Anesthesiology 1963; 24: 111
  • 15 Chernik DA, Gillings D, Laine H et al. Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 1994; 10: 244-251
  • 16 Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth 1995; 7: 89-91
  • 17 Frieling T, Heise J, Kreysel C et al. Sedation-associated complications in endoscopy prospective multicentre survey of 191142 patients. Z Gastroenterol 2013; 51: 568-572
  • 18 McCaffery M, Pasero C. Using the 0-to-10 pain rating scale. Am J Nurs 2001; 101; 81-82
  • 19 Kim SG. The elderly also deserves to undergo therapeutic endoscopy safely under sedation with propofol by gastroenterologists. Gut Liver 2015; 9: 1-2
  • 20 García-Suárez C, López-Rosés L, Olivencia P et al. Sedation with propofol controlled by endoscopists during percutaneous endoscopic gastrostomy. Rev Esp Enferm Dig 2010; 102: 249-256
  • 21 Garewal D, Waikar P. Propofol sedation for ERCP procedures: a dilemna? Observations from an anesthesia perspective. Diagn Ther Endosc 2012; 2012: 639190
  • 22 Frieling T, Heise J, Kreysel C et al. Sedation-associated complications in endoscopy – prospective multicentre survey of 191142 patients. Z Gastroenterol 2013; 51: 568-572
  • 23 Külling D, Orlandi M, Inauen W. Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary?. Gastrointest Endosc 2007; 66: 443-449
  • 24 Eisen M, Baron T, Dominitz J et al. Complications of upper GI endoscopy. Gastrointest Endosc 2002; 55: 784-793
  • 25 Berzin TM, Sanaka S, Barnett SR et al. A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation. Gastrointest Endosc 2011; 73: 710-717
  • 26 Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: a risk factor analysis. Scand J Gastroenterol 2008; 43: 368-374
  • 27 Agostoni M, Fanti L, Gemma M et al. Adverse events during monitored anesthesia care for GI endoscopy: an 8-year experience. Gastrointest Endosc 2011; 74: 266-275
  • 28 Amornyotin S, Chalayonnawin W, Kongphlay S. Deep sedation for endoscopic retrograde cholangiopancreatography: a comparison between clinical assessment and Narcotrend(TM) monitoring. Med Devices (Auckl) 2011; 4: 43-49
  • 29 Nayar DS, Guthrie WG, Goodman A et al. Comparison of propofol deep sedation versus moderate sedation during endosonography. Dig Dis Sci 2010; 55: 2537-2544
  • 30 Amornyotin S, Chalayonnavin W, Kongphlay S. Propofol-based sedation does not increase rate of complication during percutaneous endoscopic gastrostomy procedure. Gastroenterol Res Pract 2011; 2011: 134819
  • 31 American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002; 96: 1004-1017
  • 32 Yusof F, Raymond G, Sahai AV. Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. Gastrointest Endosc 2004; 60: 356-360
  • 33 Deenadayalu VP, Eid EF, Goff JS et al. Non-anesthesiologist administered propofol sedation for endoscopic procedures: a worldwide safety review. Gastrointest Endosc 2008; 67: AB107
  • 34 Faigel DO, Baron TH, Goldstein JL et al. Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc 2002; 5: 613-617
  • 35 Nelson DB, Barkun AN, Block KP et al. Propofol use during gastrointestinal endoscopy. Gastrointest Endosc 2001; 7: 876-879
  • 36 Qadeer MA, Vargo JJ, Dumot JA et al. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology 2009; 136: 1568-1576
  • 37 van Loon K, van Rheineck Leyssius AAT, van Zaane B et al. Capnography during deep sedation with propofol by non-anesthesiologists: a randomized controlled trial. Anesth Analg 2014; 119: 49-55
  • 38 Lera dos Santos ME, Maluf-Filho F, Chaves DM et al. Deep sedation during gastrointestinal endoscopy: propofol-fentanyl and midazolam-fentanyl regimens. World J Gastroenterol 2013; 19: 3439-344